Open access
Nov 2026
Impact of daratumumab on stem cell collection in patients with AL amyloidosis
Autologous stem cell transplantation following high-dose melphalan is an effective consolidation therapy for the initial treatment of systemic AL amyloidosis. While quadruplet induction therapy involving daratumumab is the standard-of-care, its impact on stem cell yield has not been studied. Furthermore, the rela...
Joseph Kauer, Tobias Dittrich, Andreas Smeykal et al.
· BMC Cancer · 0 citations